ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0450

Knowledge, Attitudes, and Intention Towards HPV Vaccination Among Reproductive-Age Women with Rheumatic Diseases

Galilea Rodriguez1, Ana Rodriguez-Flores2, Mara Ponce3, Anahí Carrazco Chapa4, Karen Aglae Chavez-Olivo1, Aldo Patricio Romero-Avila1, Jesus Cardenas-de la Garza3, CASSANDRA SKINNER TAYLOR5, Lorena Perez-Barbosa6 and Dionicio Galarza-Delgado7, 1Hospital Universitario "Dr Jose Eleuterio Gonzalez", Monterrey, Mexico, 2Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 3Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 4Hospital Universitario Jose Eleuterio Gonzalez, UANL, Rheumatology, Monterrey, Mexico, Monterrey, Mexico, 5HOSPITAL UNIVERSITARIO DR JOSE ELEUTERIO GONZALEZ, MONTERREY, Mexico, 6Hospital Universitario, UANL, Monterrey, Mexico, 7UANL Hospital Universitario, Monterrey, Nuevo León, Mexico

Meeting: ACR Convergence 2024

Keywords: Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Reproductive Issues in Rheumatic Disorders Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Women with autoimmune rheumatic disease (ARDs) have a higher risk for cervical cancer due to the persistence of the HPV infection. HPV vaccination is crucial in our population ascribed to a higher incidence of cervical cancer and high mortality rates. According to the literature vaccination rates remain low, and factors such as knowledge, beliefs, attitudes, and acceptability are associated with the patient’s decision to be vaccinated. We aimed to identify the level of knowledge, attitudes, and intentions towards HPV vaccination among reproductive-age women with ARDs.

Methods: An observational, descriptive, transversal study was conducted among reproductive-age women (18 – 45 years) with ARDs who attended the Rheumatology clinic in a University Hospital. They were asked to answer a self-reported and validated survey “knowledge, attitudes, and intentions towards HPV vaccination” (KAI-VPH) applied in Spanish from May 2024 to June 2024. The Kolmogorov–Smirnov, Spearman, Kendall’s Tau, and Mann–Whitney U tests were employed. Demographic characteristics are presented as frequencies, percentages, median, mean, standard deviation (SD), and interquartile range (IQR).

Results: A total of 71 reproductive-age women with ARDs were included. The median age was 38.84 (SD: 7.49). The sociodemographic and clinical characteristics of the patient’s knowledge and intentions toward HPV vaccination are shown in Table 1. We found that only 21 (29.6%) women had their HPV vaccination status complete even if 84.5% had heard about the vaccine before. A total of 63.4% had a history of cervical cytology performed once in their lives and the majority had it in the last year (60%). We found a statistically significant positive correlation between the knowledge about HPV and vaccination and the education level of the patients (r= 0.392, p= 0.001). 

Regarding attitude, 56.3% believed that based on the sexual practices in the country of the population studied, there is a high risk of contracting the infection. Most participants consider contracting HPV to be a serious disease (43.7%), and there was a statistically significant positive correlation with the performance of cervical cytology among patients (p=0.015). A total of 54.9% strongly agreed that gynecologists should recommend the vaccine to their patients, even if they come from conservative families, and the same percentage strongly agreed to recommend vaccination to their friends, even if they come from conservative families. The intention to vaccinate at the end of the survey was assessed among the 50 women who had not been previously vaccinated or did not know if they were vaccinated, and a statistically significant correlation was found between education level and positive vaccination intention (r=0.243, p=0.044).

Conclusion: Although aware of the HPV vaccine, less than a third of our population is vaccinated. More than half have taken cervical cytology at least once in their lifetime, the majority in the last year. Most of our population had a moderate level of knowledge. The attitude towards HPV vaccination was mainly positive and associated with a higher level of education among women.

Supporting image 1

Table 1. Sociodemographic characteristics


Disclosures: G. Rodriguez: None; A. Rodriguez-Flores: None; M. Ponce: None; A. Carrazco Chapa: None; K. Chavez-Olivo: None; A. Romero-Avila: None; J. Cardenas-de la Garza: None; C. SKINNER TAYLOR: None; L. Perez-Barbosa: None; D. Galarza-Delgado: None.

To cite this abstract in AMA style:

Rodriguez G, Rodriguez-Flores A, Ponce M, Carrazco Chapa A, Chavez-Olivo K, Romero-Avila A, Cardenas-de la Garza J, SKINNER TAYLOR C, Perez-Barbosa L, Galarza-Delgado D. Knowledge, Attitudes, and Intention Towards HPV Vaccination Among Reproductive-Age Women with Rheumatic Diseases [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/knowledge-attitudes-and-intention-towards-hpv-vaccination-among-reproductive-age-women-with-rheumatic-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/knowledge-attitudes-and-intention-towards-hpv-vaccination-among-reproductive-age-women-with-rheumatic-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology